IMUN Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (18 Oct 2023 @ 12:27):

Immune Therapeutics, Inc. does not have significant operations. The company was formerly known as TNI BioTech, Inc. and changed its name to Immune Therapeutics, Inc...

Stats
Today's Volume	1 830.00
Average Volume	13 338.00
Market Cap	7.78M
EPS	$-0.00467 ( 2023-09-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0.0788
ATR14	$0.00900 (11.25%)

Insider Trading

Date	Person	Action	Amount	type
2023-02-10	Farmer Glen A	Buy	409 000	Common Stock
2022-07-25	H. Louis Salomonsky Jr. Revocable Trust	Sell	0	Common Stock
2022-07-25	Salomonsky Henry Louis	Buy	0	Common Stock
2022-07-25	Salomonsky Henry Louis	Sell	0	Common Stock
2022-08-02	Farmer Glen A	Buy	0

INSIDER POWER
100.00
Last 55 transactions
Buy: 10 341 712 \| Sell: 6 700 401

Volume Correlation

Long: -0.09 (neutral)

Short: -0.34 (neutral)

Signal:(38.678) Neutral

Immune Therapeutics, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Immune Therapeutics, Inc. Correlation - Currency/Commodity

-0.76
( moderate negative )

-0.65
( moderate negative )

0.00
( neutral )

-0.76
( moderate negative )

-0.32
( neutral )

0.59
( weak )

Immune Therapeutics, Inc. Financials

Annual	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.160

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.160

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$7.43

FY	2020
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$3.44

Financial Reports:

No articles found.

Immune Therapeutics, Inc.

Immune Therapeutics, Inc. does not have significant operations. The company was formerly known as TNI BioTech, Inc. and changed its name to Immune Therapeutics, Inc. in October 2014. Immune Therapeutics, Inc. is headquartered in Orlando, Florida.